Immunization, Hib3 in Latvia
Latvia: Immunization, Hib3 was 97.0% in 2024. ▲ Rising
Immunization, Hib3 in Latvia, 1994–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Latvia is 97.0%, measured in 2024.
The figure is down 1.0% on the previous year and up 5.4% over ten years.
Over the whole period, immunization, hib3 in Latvia peaked at 99.0% in 2005 and was at its lowest, 10.0%, in 1994.
Latvia ranks 29th of 191 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 31 years of available data.
Immunization, Hib3 in Latvia, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1994 | 10.0% | — |
| 1995 | 58.0% | +480.0% |
| 1996 | 35.0% | -39.7% |
| 1997 | 67.0% | +91.4% |
| 1998 | 47.0% | -29.9% |
| 1999 | 76.0% | +61.7% |
| 2000 | 79.0% | +3.9% |
| 2001 | 84.0% | +6.3% |
| 2002 | 87.0% | +3.6% |
| 2003 | 96.0% | +10.3% |
| 2004 | 98.0% | +2.1% |
| 2005 | 99.0% | +1.0% |
| 2006 | 96.0% | -3.0% |
| 2007 | 94.0% | -2.1% |
| 2008 | 94.0% | +0.0% |
| 2009 | 94.0% | +0.0% |
| 2010 | 90.0% | -4.3% |
| 2011 | 91.0% | +1.1% |
| 2012 | 90.0% | -1.1% |
| 2013 | 94.0% | +4.4% |
| 2014 | 92.0% | -2.1% |
| 2015 | 94.0% | +2.2% |
| 2016 | 98.0% | +4.3% |
| 2017 | 98.0% | +0.0% |
| 2018 | 96.0% | -2.0% |
| 2019 | 99.0% | +3.1% |
| 2020 | 99.0% | +0.0% |
| 2021 | 93.0% | -6.1% |
| 2022 | 95.0% | +2.2% |
| 2023 | 98.0% | +3.2% |
| 2024 | 97.0% | -1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 48.8% | 10.0% | 76.0% | 6 |
| 2000s | 92.1% | 79.0% | 99.0% | 10 |
| 2010s | 94.2% | 90.0% | 99.0% | 10 |
| 2020s | 96.4% | 93.0% | 99.0% | 5 |
Countries ranked near Latvia
- 29 Albania 97.0% compare
- 29 Bangladesh 97.0% compare
- 29 Belgium 97.0% compare
- 29 Egypt 97.0% compare
- 29 Korea 97.0% compare
- 29 Malta 97.0% compare
- 29 Naoero 97.0% compare
- 29 Nepal 97.0% compare
- 29 Norway 97.0% compare
- 29 Saudi Arabia 97.0% compare
- 29 Singapore 97.0% compare
- 29 Sri Lanka 97.0% compare
- 29 Saint Kitts and Nevis 97.0% compare
- 29 Tajikistan 97.0% compare
- 29 Tunisia 97.0% compare
- 29 Viet Nam 97.0% compare
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0264 units per person (2025)
- Population ages 05-09, male, annual growth rate -4.21 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0285 units per person (2025)
- Population ages 10-14, female, annual growth rate 2.1 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in Latvia?
- Immunization, hib3 in Latvia was 97.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Latvia?
- The highest recorded value was 99.0% in 2005.
- What is the lowest immunization, hib3 recorded in Latvia?
- The lowest recorded value was 10.0% in 1994.
- How does Latvia rank for immunization, hib3?
- Latvia ranks 29th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Latvia?
- Over the last ten years it is up 5.4%. The long-run trend across the full record is rising.
- Where does this Latvia data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 31 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.